XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jan. 06, 2022
Jan. 06, 2022
Jan. 02, 2021
Jan. 02, 2017
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2019
Jan. 01, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock options outstanding         5,554,861   5,520,861    
Stock options outstanding weighted average exercise price         $ 1.83   $ 1.84    
Stock options. intrinsic value         $ 0        
Option to purchase shares of common stock         50,000        
Stock options exercise price         $ 1.21        
Stock options, weighted average remaining contractual term         6 years 1 month 9 days   6 years 3 months 25 days    
Warrant shares, outstanding         6,148,630   6,132,630    
Option exercise price                
Employees [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Share based compensation expense         $ 48,828        
Unamortized stock option expense             $ 205,592    
Non-Employees [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Share based compensation expense         $ 166,518        
Unamortized stock option expense             $ 1,764,762    
Weighted average period for unamortized stock compensation             2 years 10 months 6 days    
Share-Based Payment Arrangement, Option [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Option to purchase shares of common stock         50,000 366,000      
Stock options exercise price         $ 1.21 $ 5.60      
Share based compensation expense         $ 215,346 $ 345,975      
Share-Based Payment Arrangement, Option [Member] | Settlement of Accrued Compensation [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Option to purchase shares of common stock   50,000              
Stock options exercise price   $ 1.21              
Stock options, fair value   $ 68,614              
Stock options, weighted average remaining contractual term   10 years              
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Share based compensation expense         176,949 344,499      
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Share based compensation expense         $ 38,397 1,476      
Equity Option [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Unamortized stock option expense             $ 1,970,354    
2016 Plan [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of additional shares granted     569,826 564,378          
Number of shares available for grant       1,693,134 6,175,489   5,438,449   737,040
Number of shares for employee benefit         172,762     564,278  
Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of conversion of shares of notes and interest         43,666        
Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Option to purchase shares of common stock   16,000              
Share based compensation expense         $ 20,433 $ 0      
Warrant shares, outstanding         6,148,630        
Class of warrant or right, outstanding, weighted average exercise price         $ 3.37        
Class of warrant or right, outstanding, intrinsic value         $ 0        
Warrants to purchase common stock 16,000 16,000              
Options expiration period 5 years                
Option exercise price   $ 1.25